CRISPR-Cas-based transcriptional activators allow genetic engineers to specifically induce expression of one or many target genes in trans. Here we review the many design variations of these versatile tools and compare their effectiveness in different eukaryotic systems. Lastly, we highlight several applications of programmable transcriptional activation to interrogate and engineer complex biological processes.
Get full access to this article
View all access options for this article.
References
1.
AdliM. The CRISPR tool kit for genome editing and beyond. Nat Commun. 2018; 9:1911. DOI: 10.1038/s41467-018-04252-2.
2.
GarneauJE, DupuisME, VillionM, et al.The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature. 2010; 468:67–71. DOI: 10.1038/nature09523.
3.
GasiunasG, BarrangouR, HorvathP, et al.Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A. 2012; 109:E2579–E2586. DOI: 10.1073/pnas.1208507109.
4.
JinekM, ChylinskiK, FonfaraI, et al.A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012; 337:816–821. DOI: 10.1126/science.1225829.
5.
QiLS, LarsonMH, GilbertLA, et al.Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell. 2013; 152:1173–1183. DOI: 10.1016/j.cell.2013.02.022.
6.
MaliP, AachJ, StrangesPB, et al.CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol. 2013; 31:833–838. DOI: 10.1038/nbt.2675.
7.
GreenMR. Eukaryotic transcription activation: Right on target. Mol Cell. 2005; 18:399–402. DOI: 10.1016/j.molcel.2005.04.017.
8.
PetrenkoN, JinY, DongL, et al.Requirements for RNA polymerase II preinitiation complex formation in vivo. Elife. 2019; 8:e43654. DOI: 10.7554/eLife.43654.
9.
AllenBL, TaatjesDJ. The Mediator complex: A central integrator of transcription. Nat Rev Mol Cell Biol. 2015; 16:155–166. DOI: 10.1038/nrm3951.
10.
BoijaA, KleinIA, SabariBR, et al.Transcription factors activate genes through the phase-separation capacity of their activation domains. Cell. 2018; 175:1842–1855 e1816. DOI: 10.1016/j.cell.2018.10.042.
11.
SadowskiI, MaJ, TriezenbergS, et al.GAL4-VP16 is an unusually potent transcriptional activator. Nature. 1988; 335:563–564. DOI: 10.1038/335563a0.
12.
BeerliRR, SegalDJ, DreierB, et al.Toward controlling gene expression at will: Specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc Natl Acad Sci U S A. 1998; 95:14628–14633. DOI: 10.1073/pnas.95.25.14628.
LiZ, ZhangD, XiongX, et al.A potent Cas9-derived gene activator for plant and mammalian cells. Nat Plants. 2017; 3:930–936. DOI: 10.1038/s41477-017-0046-0.
15.
SchmitzML, BaeuerlePA. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J. 1991; 10:3805–3817.
16.
HardwickJM, TseL, ApplegrenN, et al.The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16. J Virol. 1992; 66:5500–5508.
17.
GreenM, SchuetzTJ, SullivanEK, et al.A heat shock-responsive domain of human HSF1 that regulates transcription activation domain function. Mol Cell Biol. 1995; 15:3354–3362. DOI: 10.1128/mcb.15.6.3354
18.
StockingerEJ, GilmourSJ, ThomashowMF. Arabidopsis thaliana CBF1 encodes an AP2 domain-containing transcriptional activator that binds to the C-repeat/DRE, a cis-acting DNA regulatory element that stimulates transcription in response to low temperature and water deficit. Proc Natl Acad Sci U S A. 1997; 94:1035–1040. DOI: 10.1073/pnas.94.3.1035.
19.
TiwariSB, BelachewA, MaSF, et al.The EDLL motif: A potent plant transcriptional activation domain from AP2/ERF transcription factors. Plant J. 2012; 70:855–865. DOI: 10.1111/j.1365-313X.2012.04935.x.
20.
YoungJK, GasiorSL, JonesS, et al.The repurposing of type I-E CRISPR-Cascade for gene activation in plants. Commun Biol. 2019; 2:383. DOI: 10.1038/s42003-019-0637-6.
21.
ZhuW, YangB, ChittoorJM, et al.AvrXa10 contains an acidic transcriptional activation domain in the functionally conserved C terminus. Mol Plant Microbe Interact. 1998; 11:824–832. DOI: 10.1094/MPMI.1998.11.8.824.
BabuMM. The contribution of intrinsically disordered regions to protein function, cellular complexity, and human disease. Biochem Soc Trans. 2016; 44:1185–1200. DOI: 10.1042/BST20160172.
24.
KwonI, KatoM, XiangS, et al.Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains. Cell. 2013; 155:1049–1060. DOI: 10.1016/j.cell.2013.10.033.
25.
BoehningM, Dugast-DarzacqC, RankovicM, et al.RNA polymerase II clustering through carboxy-terminal domain phase separation. Nat Struct Mol Biol. 2018; 25:833–840. DOI: 10.1038/s41594-018-0112-y.
26.
ChengAW, WangH, YangH, et al.Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res. 2013; 23:1163–1171. DOI: 10.1038/cr.2013.122.
27.
FarzadfardF, PerliSD, LuTK. Tunable and multifunctional eukaryotic transcription factors based on CRISPR/Cas. ACS Synth Biol. 2013; 2:604–613. DOI: 10.1021/sb400081r.
28.
GilbertLA, LarsonMH, MorsutL, et al.CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell. 2013; 154:442–451. DOI: 10.1016/j.cell.2013.06.044.
29.
KearnsNA, GengaRM, EnuamehMS, et al.Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells. Development. 2014; 141:219–223. DOI: 10.1242/dev.103341.
30.
MaederML, LinderSJ, CascioVM, et al.CRISPR RNA-guided activation of endogenous human genes. Nat Methods. 2013; 10:977–979. DOI: 10.1038/nmeth.2598
31.
Perez-PineraP, KocakDD, VockleyCM, et al.RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods. 2013; 10:973–976. DOI: 10.1038/nmeth.2600.
32.
PiatekA, AliZ, BaazimH, et al.RNA-guided transcriptional regulation in planta via synthetic dCas9-based transcription factors. Plant Biotechnol J. 2015; 13:578–589. DOI: 10.1111/pbi.12284.
33.
KonermannS, BrighamMD, TrevinoAE, et al.Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. 2015; 517:583–588. DOI: 10.1038/nature14136.
34.
ZalatanJG, LeeME, AlmeidaR, et al.Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell. 2015; 160:339–350. DOI: 10.1016/j.cell.2014.11.052.
35.
TanenbaumME, GilbertLA, QiLS, et al.A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell. 2014; 159:635–646. DOI: 10.1016/j.cell.2014.09.039.
36.
KuniiA, HaraY, TakenagaM, et al.Three-component repurposed technology for enhanced expression: Highly accumulable transcriptional activators via branched tag arrays. CRISPR J. 2018; 1:337–347. DOI: 10.1089/crispr.2018.0009.
37.
ZetscheB, GootenbergJS, AbudayyehOO, et al.Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell. 2015; 163:759–771. DOI: 10.1016/j.cell.2015.09.038.
38.
ZhangX, WangJ, ChengQ, et al.Multiplex gene regulation by CRISPR-ddCpf1. Cell Discov. 2017; 3:17018. DOI: 10.1038/celldisc.2017.18.
39.
TakYE, KleinstiverBP, NunezJK, et al.Inducible and multiplex gene regulation using CRISPR-Cpf1-based transcription factors. Nat Methods. 2017; 14:1163–1166. DOI: 10.1038/nmeth.4483.
40.
ZhangX, XuL, FanR, et al.Genetic editing and interrogation with Cpf1 and caged truncated pre-tRNA-like crRNA in mammalian cells. Cell Discov. 2018; 4:36. DOI: 10.1038/s41421-018-0035-0.
41.
ZhangX, WangW, ShanL, et al.Gene activation in human cells using CRISPR/Cpf1-p300 and CRISPR/Cpf1-SunTag systems. Protein Cell. 2018; 9:380–383. DOI: 10.1007/s13238-017-0491-6.
42.
NihongakiY, OtabeT, UedaY, et al.A split CRISPR-Cpf1 platform for inducible genome editing and gene activation. Nat Chem Biol. 2019; 15:882–888. DOI: 10.1038/s41589-019-0338-y.
43.
KimD, KimJ, HurJK, et al.Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells. Nat Biotechnol. 2016; 34:863–868. DOI: 10.1038/nbt.3609.
44.
KleinstiverBP, TsaiSQ, PrewMS, et al.Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells. Nat Biotechnol. 2016; 34:869–874. DOI: 10.1038/nbt.3620.
45.
SinghD, MallonJ, PoddarA, et al.Real-time observation of DNA target interrogation and product release by the RNA-guided endonuclease CRISPR Cpf1 (Cas12a). Proc Natl Acad Sci U S A. 2018; 115:5444–5449. DOI: 10.1073/pnas.1718686115.
46.
ZetscheB, HeidenreichM, MohanrajuP, et al.Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array. Nat Biotechnol. 2017; 35:31–34. DOI: 10.1038/nbt.3737.
47.
MakarovaKS, WolfYI, AlkhnbashiOS, et al.An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol. 2015; 13:722–736. DOI: 10.1038/nrmicro3569.
48.
AndersonGM, FreytagSO. Synergistic activation of a human promoter in vivo by transcription factor Sp1. Mol Cell Biol. 1991; 11:1935–1943. DOI: 10.1128/mcb.11.4.1935.
49.
CareyM, LinYS, GreenMR, et al.A mechanism for synergistic activation of a mammalian gene by GAL4 derivatives. Nature. 1990; 345:361–364. DOI: 10.1038/345361a0.
50.
PetterssonM, SchaffnerW. Synergistic activation of transcription by multiple binding sites for NF-kappa B even in absence of co-operative factor binding to DNA. J Mol Biol. 1990; 214:373–380. DOI: 10.1016/0022-2836(90)90187-q.
51.
Perez-PineraP, OusteroutDG, BrungerJM, et al.Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nat Methods. 2013; 10:239–242. DOI: 10.1038/nmeth.2361.
52.
GilbertLA, HorlbeckMA, AdamsonB, et al.Genome-scale CRISPR-mediated control of gene repression and activation. Cell. 2014; 159:647–661. DOI: 10.1016/j.cell.2014.09.029.
53.
HuJ, LeiY, WongWK, et al.Direct activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors. Nucleic Acids Res. 2014; 42:4375–4390. DOI: 10.1093/nar/gku109.
54.
DeanerM, AlperHS. Systematic testing of enzyme perturbation sensitivities via graded dCas9 modulation in Saccharomyces cerevisiae. Metab Eng. 2017; 40:14–22. DOI: 10.1016/j.ymben.2017.01.012.
55.
GongX, ZhangT, XingJ, et al.Positional effects on efficiency of CRISPR/Cas9-based transcriptional activation in rice plants. aBIOTECH. 2020; 1:1–5. DOI: 10.1007/s42994-019-00007-9.
56.
ChavezA, TuttleM, PruittBW, et al.Comparison of Cas9 activators in multiple species. Nat Methods. 2016; 13:563–567. DOI: 10.1038/nmeth.3871.
57.
LinS, Ewen-CampenB, NiX, et al.In vivo transcriptional activation using CRISPR/Cas9 in drosophila. Genetics. 2015; 201:433–442. DOI: 10.1534/genetics.115.181065.
58.
FuY, FodenJA, KhayterC, et al.High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol. 2013; 31:822–826. DOI: 10.1038/nbt.2623.
59.
PattanayakV, LinS, GuilingerJP, et al.High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol. 2013; 31:839–843. DOI: 10.1038/nbt.2673.
60.
PapikianA, LiuW, Gallego-BartolomeJ, et al.Site-specific manipulation of Arabidopsis loci using CRISPR-Cas9 SunTag systems. Nat Commun. 2019; 10:729. DOI: 10.1038/s41467-019-08736-7.
61.
NormanTM, HorlbeckMA, ReplogleJM, et al.Exploring genetic interaction manifolds constructed from rich single-cell phenotypes. Science. 2019; 365:786–793. DOI: 10.1126/science.aax4438.
62.
LiuY, YuC, DaleyTP, et al.CRISPR activation screens systematically identify factors that drive neuronal fate and reprogramming. Cell Stem Cell. 2018; 23:758–771 e758. DOI: 10.1016/j.stem.2018.09.003.
63.
BoettcherM, TianR, BlauJA, et al.Dual gene activation and knockout screen reveals directional dependencies in genetic networks. Nat Biotechnol. 2018; 36:170–178. DOI: 10.1038/nbt.4062
64.
YangJ, RajanSS, FriedrichMJ, et al.Genome-Scale CRISPRa Screen Identifies Novel Factors for Cellular Reprogramming. Stem Cell Reports. 2019; 12:757–771. DOI: 10.1016/j.stemcr.2019.02.010.
65.
JoungJ, EngreitzJM, KonermannS, et al.Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood. Nature. 2017; 548:343–346. DOI: 10.1038/nature23451.
66.
ChongZS, OhnishiS, YusaK, et al.Pooled extracellular receptor-ligand interaction screening using CRISPR activation. Genome Biol. 2018; 19:205. DOI: 10.1186/s13059-018-1581-3.
67.
RamkumarP, KampmannM. CRISPR-based genetic interaction maps inform therapeutic strategies in cancer. Transl Cancer Res. 2018; 7:S61-S67. DOI: 10.21037/tcr.2018.01.02.
68.
HorlbeckMA, GilbertLA, VillaltaJE, et al.Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. Elife. 2016; 5. DOI: 10.7554/eLife.19760.
69.
SansonKR, HannaRE, HegdeM, et al.Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nat Commun. 2018; 9:5416. DOI: 10.1038/s41467-018-07901-8.
70.
BraunCJ, BrunoPM, HorlbeckMA, et al.Versatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbation. Proc Natl Acad Sci U S A. 2016; 113:E3892–E3900. DOI: 10.1073/pnas.1600582113.
71.
WangensteenKJ, WangYJ, DouZ, et al.Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform. Hepatology. 2018; 68:663–676. DOI: 10.1002/hep.29626.
72.
ZhouH, LiuJ, ZhouC, et al.In vivo simultaneous transcriptional activation of multiple genes in the brain using CRISPR-dCas9-activator transgenic mice. Nat Neurosci. 2018; 21:440–446. DOI: 10.1038/s41593-017-0060-6.
73.
SchogerE, CarrollKJ, IyerLM, et al.CRISPR-mediated activation of endogenous gene expression in the postnatal heart. Circ Res. 2020; 126:6–24. DOI: 10.1161/CIRCRESAHA.118.314522.
74.
WangG, ChowRD, BaiZ, et al.Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity. Nat Immunol. 2019; 20:1494–1505. DOI: 10.1038/s41590-019-0500-4.
75.
HsuMN, HuangKL, YuFJ, et al.Coactivation of endogenous Wnt10b and Foxc2 by CRISPR activation enhances BMSC osteogenesis and promotes calvarial bone regeneration. Mol Ther. 2020; 28:441–451. DOI: 10.1016/j.ymthe.2019.11.029.
76.
MatharuN, RattanasophaS, TamuraS, et al.CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency. Science. 2019; 363. DOI: 10.1126/science.aau0629.
77.
Ewen-CampenB, Yang-ZhouD, FernandesVR, et al.Optimized strategy for in vivo Cas9-activation in Drosophila. Proc Natl Acad Sci U S A. 2017; 114:9409–9414. DOI: 10.1073/pnas.1707635114.
78.
JiaY, XuRG, RenX, et al.Next-generation CRISPR/Cas9 transcriptional activation in Drosophila using flySAM. Proc Natl Acad Sci U S A. 2018; 115:4719–4724. DOI: 10.1073/pnas.1800677115.
79.
ZirinJ, HuY, LiuL, et al.Large-scale transgenic drosophila resource collections for loss- and gain-of-function studies. Genetics. 2020; 214:755–767. DOI: 10.1534/genetics.119.302964.
80.
LongL, GuoH, YaoD, et al.Regulation of transcriptionally active genes via the catalytically inactive Cas9 in C. elegans and D. rerio. Cell Res. 2015; 25:638–641. DOI: 10.1038/cr.2015.35.
81.
LowderLG, ZhangD, BaltesNJ, et al.A CRISPR/Cas9 Toolbox for multiplexed plant genome editing and transcriptional regulation. Plant Physiol. 2015; 169:971–985. DOI: 10.1104/pp.15.00636.
82.
ParkJJ, DempewolfE, ZhangW, et al.RNA-guided transcriptional activation via CRISPR/dCas9 mimics overexpression phenotypes in Arabidopsis. PLoS One. 2017; 12:e0179410. DOI: 10.1371/journal.pone.0179410.
83.
LeeJE, NeumannM, DuroDI, et al.CRISPR-based tools for targeted transcriptional and epigenetic regulation in plants. PLoS One. 2019; 14:e0222778. DOI: 10.1371/journal.pone.0222778.
84.
LowderLG, ZhouJ, ZhangY, et al.Robust transcriptional activation in plants using multiplexed CRISPR-Act2.0 and mTALE-Act Systems. Mol Plant. 2018; 11:245–256. DOI: 10.1016/j.molp.2017.11.010.
85.
JensenED, FerreiraR, JakociunasT, et al.Transcriptional reprogramming in yeast using dCas9 and combinatorial gRNA strategies. Microb Cell Fact. 2017; 16:46. DOI: 10.1186/s12934-017-0664-2.
86.
LianJ, HamediRadM, HuS, et al.Combinatorial metabolic engineering using an orthogonal tri-functional CRISPR system. Nat Commun. 2017; 8:1688. DOI: 10.1038/s41467-017-01695-x.
87.
MaselkoM, FeltmanN, UpadhyayA, et al.Engineering multiple species-like genetic incompatibilities in insects. Nat Commun. 2020; 11:4468. DOI: 10.1038/s41467-020-18348-1.
88.
SelmaS, Bernabe-OrtsJM, Vazquez-VilarM, et al.Strong gene activation in plants with genome-wide specificity using a new orthogonal CRISPR/Cas9-based programmable transcriptional activator. Plant Biotechnol J. 2019; 17:1703–1705. DOI: 10.1111/pbi.13138.
